drugset / Trial / NCT07692867

Efficacy and Safety Study of Tunodafil Hydrochloride Tablets in Erectile Dysfunction

NCT07692867 ↗

Phase 3 Completed 780 enrolled Yangtze River Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of Tunodafil Hydrochloride Tablets in men with erectile dysfunction.

Timeline

Start
2021-04-01
Primary completion
2021-11-23
Completion
2022-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Tunodafil Small molecule 50 mg —
Subject Tunodafil Small molecule 100 mg —

Indications